Key result
Comorbid anxiety and depression symptoms accounted for 28.3% of the variance in asthma-related quality of life, with depression independently showing a significant negative association.
Why the study?
Are comorbid anxiety and depression associated with asthma-related quality of life and symptom perception in adults?
Cross-Sectional (n=110)
Are comorbid anxiety and depression associated with asthma-related quality of life and symptom perception in adults?
In adult asthma patients, comorbid depression is negatively associated with asthma-related quality of life, while anxiety is associated with increased perception of panic-fear and hyperventilation symptoms.
Supports considering comorbid depression in asthma assessment; leaves open whether treatment improves quality of life.
BACKGROUND AND OBJECTIVE: There are limited data on the association and interaction between anxiety and depression comorbidity and asthma-related quality of life (AQOL) and symptom perception. This study evaluated these associations in patients subsequent to an emergency department (ED) visit for asthma. METHODS: This was a cross-sectional study of 110 (38 male) adult asthma patients (mean age 42 years), who had visited an ED in the previous 18 months. Participants completed the hospital anxiety and depression scale, measures of AQOL and the asthma symptom checklist. RESULTS: Depression symptoms independently showed a significant negative association with AQOL after controlling for depression/anxiety, age, gender, smoking status and ED visits in the previous 12 months (ED-12). Overall, anxiety and depression symptoms accounted for 28.3% of the variance in AQOL. Greater anxiety was associated with increased perception of asthma-specific panic-fear and hyperventilation symptoms during an asthma attack, irrespective of depression status. Categorical analyses of groups of patients, differentiated by psychometric properties on the hospital anxiety and depression scale (anxiety vs normal, anxiety and depression vs normal depression) confirmed most results. However, for the anxiety group there was a significant association with the AQOL domains of emotional functioning and response to environmental stimuli, after controlling for depression symptoms. CONCLUSIONS: The negative association of depression symptom scores with AQOL and of anxiety with increased panic-fear and hyperventilation symptoms suggests a potential role for interventions addressing this psychological comorbidity, in order to improve AQOL.
No takes yet. Share an insight, caveat, or question.
Deshmukh et al. (2008) conducted a cross-sectional in Asthma (n=110). Anxiety and depression symptoms vs. Normal anxiety and depression status was evaluated on Asthma-related quality of life (AQOL). Comorbid anxiety and depression symptoms accounted for 28.3% of the variance in asthma-related quality of life, with depression independently showing a significant negative association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: